$REAL
TheRealReal, Inc. Stock $real

$real Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000157322124000125 Filed on November 04, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$147.8M
YoY Change		10.95%
Cost Of Revenue		$37.04M
YoY Change		-5.26%
Gross Profit		$110.7M
YoY Change		17.69%
Gross Profit Margin		74.93%
Selling, General & Admin		$47.51M
YoY Change		6.08%
% of Gross Profit		42.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$8.270M
YoY Change		6.85%
% of Gross Profit		7.47%
Operating Expenses		$125.3M
YoY Change		7.51%
Operating Profit		-$14.60M
YoY Change		-35.07%
Interest Expense		-$4.008M
YoY Change		-249.94%
% of Operating Profit
Other Income/Expense, Net		$744.0K
YoY Change
Pretax Income		-$17.87M
YoY Change		-21.99%
Income Tax		$72.00K
% Of Pretax Income
Net Earnings		-$17.94M
YoY Change		-21.84%
Net Earnings / Revenue		-12.14%
Basic Earnings Per Share		-$0.16
Diluted Earnings Per Share		-$0.17
COMMON SHARES
Basic Shares Outstanding	109.7M shares	108.5M shares
Diluted Shares Outstanding		112.4M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$153.2M
YoY Change		-10.32%
Cash & Equivalents	$172.2M	$153.2M
Short-Term Investments
Other Short-Term Assets		$22.68M
YoY Change		8.5%
Inventory	$23.58M	$19.92M
Prepaid Expenses
Receivables	$13.96M	$15.95M
Other Receivables		$0.00
Total Short-Term Assets	$232.7M	$211.7M
YoY Change	-1.39%	-7.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$94.44M	$95.22M
YoY Change	-9.27%	-10.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.358M	$5.251M
YoY Change	-4.78%	-4.06%
Total Long-Term Assets	$190.4M	$194.5M
YoY Change	-9.74%	-12.66%
TOTAL ASSETS
Total Short-Term Assets	$232.7M	$211.7M
Total Long-Term Assets	$190.4M	$194.5M
Total Assets	$423.1M	$406.3M
YoY Change	-5.33%	-10.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.00M	$10.80M
YoY Change	22.8%	33.47%
Accrued Expenses	$89.72M	$73.24M
YoY Change	16.33%	10.1%
Deferred Revenue	$2.441M	$3.425M
YoY Change	10.25%	108.08%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$26.60M
YoY Change
Total Short-Term Liabilities	$248.7M	$225.7M
YoY Change	31.67%	27.56%
LONG-TERM LIABILITIES
Long-Term Debt		$407.9M
YoY Change		-9.71%
Other Long-Term Liabilities	$6.144M	$7.158M
YoY Change	50.48%	74.71%
Total Long-Term Liabilities	$6.144M	$7.158M
YoY Change	50.48%	74.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$248.7M	$225.7M
Total Long-Term Liabilities	$6.144M	$7.158M
Total Liabilities	$830.5M	$751.7M
YoY Change	10.7%	1.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.254B	-$1.185B
YoY Change	11.99%	7.96%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$407.4M	-$345.4M
YoY Change
Total Liabilities & Shareholders Equity	$423.1M	$406.3M
YoY Change	-5.33%	-10.26%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$17.94M
YoY Change		-21.84%
Depreciation, Depletion And Amortization		$8.270M
YoY Change		6.85%
Cash From Operating Activities		$9.073M
YoY Change		-183.01%
INVESTING ACTIVITIES
Capital Expenditures		$6.939M
YoY Change		-14.54%
Acquisitions
YoY Change
Other Investing Activities		$461.0K
YoY Change
Cash From Investing Activities		-$6.478M
YoY Change		-20.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-162.0K
YoY Change		102.5%
NET CHANGE
Cash From Operating Activities		9.073M
Cash From Investing Activities		-6.478M
Cash From Financing Activities		-162.0K
Net Change In Cash		2.433M
YoY Change		-112.72%
FREE CASH FLOW
Cash From Operating Activities		$9.073M
Capital Expenditures		$6.939M
Free Cash Flow		$2.134M
YoY Change		-111.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Registrant Name EntityRegistrantName	TheRealReal, Inc.
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38953
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-1234222
	dei	Entity Address Address Line1 EntityAddressAddressLine1	55 Francisco Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 150
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Trading Symbol TradingSymbol	REAL
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17226000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	19921000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22246000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22677000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20766000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	211730000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	235947000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95218000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79142000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86348000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5251000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5627000	usd
CY2024Q3	us-gaap	Assets Assets	406252000	usd
CY2023Q4	us-gaap	Assets Assets	446923000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001573221
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94133
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7826000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-16708000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-335254000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	-856000	usd
	us-gaap	Restructuring Charges RestructuringCharges	196000	usd
	us-gaap	Restructuring Charges RestructuringCharges	37396000	usd
	us-gaap	Operating Expenses OperatingExpenses	415460000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-51341000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-145231000	usd
	dei	Local Phone Number LocalPhoneNumber	435-5893
	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	109691196	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153179000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175709000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104087000	usd
CY2024Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14911000	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109689946	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109689946	shares
	dei	City Area Code CityAreaCode	855
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	26600000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	82685000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	225697000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	188862000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	91274000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104856000	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	276483000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2024Q3	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	19626000	usd
CY2023Q4	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	750222000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104670500	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	104670500	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	839958000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	816325000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1185372000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1119625000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-345413000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-303299000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	406252000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	446923000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	147755000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133172000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	436489000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	405931000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	37042000	usd
	us-gaap	Marketing Expense MarketingExpense	40646000	usd
	us-gaap	Marketing Expense MarketingExpense	44460000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	47512000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44788000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	125315000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	116561000	usd
	us-gaap	Operating Expenses OperatingExpenses	376799000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14602000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-22489000	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-744000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	9209000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4177000	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1940000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2260000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6272000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6717000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	5948000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2673000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	15468000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	8018000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.45
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.45
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109016060	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102648790	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107043946	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101087793	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112418751	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102648790	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107043946	shares
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7260000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-31101000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-48000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	624000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-208000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15953000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14914000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	73242000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22487000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20094000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	92573000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7158000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4083000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	751665000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10795000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8961000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	77122000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	452421000	usd
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	131427000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	39100000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	111031000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	135702000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	110713000	usd
	us-gaap	Gross Profit GrossProfit	325458000	usd
	us-gaap	Gross Profit GrossProfit	270229000	usd
CY2024Q3	us-gaap	Marketing Expense MarketingExpense	11604000	usd
CY2023Q3	us-gaap	Marketing Expense MarketingExpense	11591000	usd
CY2024Q3	real	Operations And Technology Expense OperationsAndTechnologyExpense	66199000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	141364000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22902000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-65569000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65747000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-146779000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101087793	shares
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-316000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-327053000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	105000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-103000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7876000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-17938000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-345413000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-170092000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-103000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	446000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8920000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-41330000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-275584000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-203000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8701000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-22949000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-290019000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-65747000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-146779000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24806000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23530000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22580000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	94072000	usd
CY2023Q3	real	Operations And Technology Expense OperationsAndTechnologyExpense	61038000	usd
	real	Operations And Technology Expense OperationsAndTechnologyExpense	194593000	usd
	real	Operations And Technology Expense OperationsAndTechnologyExpense	194645000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	138959000	usd
CY2024Q3	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17866000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-146532000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	72000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	178000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	247000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17938000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22949000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-303299000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	396000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-103000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7876000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-17938000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-345413000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-170092000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9280000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-82500000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-103000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	446000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8920000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-41330000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-275584000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-203000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8701000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-22949000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-290019000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-65747000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-146779000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24806000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22580000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26293000	usd
	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	11280000	usd
	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	12999000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26293000	usd
	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	11280000	usd
	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	12999000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1844000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1565000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	3761000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	575000	usd
	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	1607000	usd
	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	1920000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	8836000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4177000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	9209000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Loss From Catastrophes LossFromCatastrophes	279000	usd
	us-gaap	Loss From Catastrophes LossFromCatastrophes	0	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	628000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	556000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	571000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2922000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-96000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9474000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-990000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1897000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-229000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2856000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-15263000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-21399000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	837000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1550000	usd
	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-5006000	usd
	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-15018000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	10036000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1499000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1148000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-71791000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	461000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
	us-gaap	Payments For Software PaymentsForSoftware	8051000	usd
	us-gaap	Payments For Software PaymentsForSoftware	9870000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9168000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25528000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35398000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	118000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	624000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	446000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22533000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1844000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1565000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	3761000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	575000	usd
	real	Issuance Of Warrant Liability Issuance Costs IssuanceOfWarrantLiabilityIssuanceCosts	374000	usd
	real	Issuance Of Warrant Liability Issuance Costs IssuanceOfWarrantLiabilityIssuanceCosts	0	usd
	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	1607000	usd
	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	1920000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	33817000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	2479000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	8836000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4177000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	9209000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Loss From Catastrophes LossFromCatastrophes	279000	usd
	us-gaap	Loss From Catastrophes LossFromCatastrophes	0	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	628000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	556000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	571000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2922000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-96000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9474000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-990000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1897000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-229000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2856000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-15263000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-21399000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	837000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1550000	usd
	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-5006000	usd
	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-15018000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	10036000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1499000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-163000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-118000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1148000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-71791000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	461000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
	us-gaap	Payments For Software PaymentsForSoftware	8051000	usd
	us-gaap	Payments For Software PaymentsForSoftware	9870000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9168000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25528000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16758000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35398000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	118000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	467000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	501000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	624000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	446000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	396000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5298000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents, restricted cash and accounts receivable. At times, such amount may exceed federally-insured limits. The Company is closely monitoring ongoing events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or other companies in the financial services industry or the financial services industry generally. The Company reduces credit risk by placing its cash, cash equivalents, restricted cash and investments with major financial institutions with high credit ratings within the United States. The Company has not experienced any realized losses on cash, cash equivalents and restricted cash to date; however, no assurances can be provided.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, there were no customers that represented 10% or more of the Company’s accounts receivable balance and there were no customers that individually exceeded 10% of the Company’s total revenue for each of the three and nine months ended September 30, 2024 and 2023.</span></div>
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4627000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-36000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22533000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-107225000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190623000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293793000	usd
	us-gaap	Interest Paid Net InterestPaidNet	10160000	usd
	us-gaap	Interest Paid Net InterestPaidNet	5522000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	197000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	227000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2293000	usd
	real	Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash	1374000	usd
	real	Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash	1070000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	381000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	608000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	10417000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	17232000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190623000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293793000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186568000	usd
	us-gaap	Interest Paid Net InterestPaidNet	10160000	usd
	us-gaap	Interest Paid Net InterestPaidNet	5522000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	197000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	227000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1834000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2293000	usd
	real	Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash	1374000	usd
	real	Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash	1070000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	10417000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	17232000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include those related to revenue recognition, including the returns reserve, standalone selling price related to consignment revenue transactions, valuation of inventory, software development costs, stock-based compensation, fair value of warrant liability, initial fair value of non-convertible notes, incremental borrowing rates related to lease liability, valuation of deferred taxes, and other contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. The disclosures provided herein should be read in conjunction with the audited financial statements and notes thereto included in our 2023 Form 10-K. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 2” in our 2023 Form 10-K for a complete summary of our significant accounting policies.</span></div>
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	14900000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	14900000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153179000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175709000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170811000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	14911000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	14914000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	15757000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168090000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190623000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186568000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	14900000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	14900000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153179000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170811000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	14911000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	14914000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168090000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190623000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186568000	usd
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown	600000	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	2300000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	2500000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	8800000	usd
CY2024Q3	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	3000000.0	usd
CY2023Q4	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	5200000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents, restricted cash and accounts receivable. At times, such amount may exceed federally-insured limits. The Company is closely monitoring ongoing events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or other companies in the financial services industry or the financial services industry generally. The Company reduces credit risk by placing its cash, cash equivalents, restricted cash and investments with major financial institutions with high credit ratings within the United States. The Company has not experienced any realized losses on cash, cash equivalents and restricted cash to date; however, no assurances can be provided.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, there were no customers that represented 10% or more of the Company’s accounts receivable balance and there were no customers that individually exceeded 10% of the Company’s total revenue for each of the three and nine months ended September 30, 2024 and 2023.</span></div>
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown	600000	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	2300000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	2500000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	8800000	usd
CY2024Q3	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	3000000.0	usd
CY2023Q4	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	5200000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153179000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	153179000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175709000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	7894737	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153179000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	153179000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175709000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	175709000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	7894737	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.71
CY2024Q3	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	19600000	usd
CY2024Q2	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	20370000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.71
CY2024Q1	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	10400000	usd
CY2024Q3	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	19600000	usd
CY2024Q2	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	20370000	usd
CY2023Q4	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	0	usd
CY2024Q3	real	Warrant Liability Issuances WarrantLiabilityIssuances	0	usd
	real	Warrant Liability Issuances WarrantLiabilityIssuances	10417000	usd
CY2024Q3	real	Warrant Liability Gain Loss WarrantLiabilityGainLoss	-744000	usd
	real	Warrant Liability Gain Loss WarrantLiabilityGainLoss	9209000	usd
CY2024Q3	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	19626000	usd
CY2024Q3	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	19626000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	187931000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	178560000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	92713000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	74473000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95218000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104087000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8100000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7600000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24400000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22900000	usd
CY2023Q3	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	300000	usd
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	7500000	usd
CY2024Q3	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	0	usd
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	0	usd
CY2023Q4	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	0	usd
CY2024Q3	real	Warrant Liability Issuances WarrantLiabilityIssuances	0	usd
	real	Warrant Liability Issuances WarrantLiabilityIssuances	10417000	usd
	real	Warrant Liability Gain Loss WarrantLiabilityGainLoss	9209000	usd
CY2024Q3	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	19626000	usd
CY2024Q3	real	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	19626000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	187931000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	178560000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	92713000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	74473000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95218000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104087000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8100000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7600000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24400000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22900000	usd
CY2023Q3	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	300000	usd
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	7500000	usd
CY2024Q3	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	0	usd
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	0	usd
CY2024Q3	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	21265000	usd
CY2023Q4	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	22204000	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	26586000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	20086000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	8519000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8118000	usd
CY2024Q3	real	Site Credit Liability SiteCreditLiability	14096000	usd
CY2024Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5872000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5012000	usd
CY2024Q3	real	Accrued Shipping AccruedShipping	3364000	usd
CY2023Q4	real	Accrued Shipping AccruedShipping	4244000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3425000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2214000	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1538000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1166000	usd
CY2024Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	7908000	usd
CY2024Q3	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	21265000	usd
CY2023Q4	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	22204000	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	26586000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	20086000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	8519000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8118000	usd
CY2024Q3	real	Site Credit Liability SiteCreditLiability	14096000	usd
CY2023Q4	real	Site Credit Liability SiteCreditLiability	14058000	usd
CY2024Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5872000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5012000	usd
CY2024Q3	real	Accrued Shipping AccruedShipping	3364000	usd
CY2023Q4	real	Accrued Shipping AccruedShipping	4244000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3425000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2214000	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1538000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1166000	usd
CY2024Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	7908000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	5583000	usd
CY2024Q1	real	Issuance Of Warrant Liability Issuance Costs IssuanceOfWarrantLiabilityIssuanceCosts	400000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8536000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22580000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	5583000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	92573000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	82685000	usd
CY2024Q1	real	Issuance Of Warrant Liability Issuance Costs IssuanceOfWarrantLiabilityIssuanceCosts	400000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7758000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8536000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22580000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26293000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	100000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	200000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	400000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	600000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	5200000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	5100000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	15600000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26293000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	100000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	200000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	400000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	600000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	5200000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	5100000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	15600000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	17900000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	1300000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	1200000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	4200000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	3800000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	26300000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2023Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1200000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	700000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	7326000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	28735000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	28496000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24542000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	21829000	usd
CY2024Q3	real	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	20200000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	131128000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17367000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	113761000	usd
	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	20690000	usd
	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	27028000	usd
	real	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Including Re Measurement Of Right Of Use Asset And Lease Liabilities RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingReMeasurementOfRightOfUseAssetAndLeaseLiabilities	4074000	usd
	real	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Including Re Measurement Of Right Of Use Asset And Lease Liabilities RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingReMeasurementOfRightOfUseAssetAndLeaseLiabilities	6006000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
	us-gaap	Operating Lease Cost OperatingLeaseCost	17900000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	1300000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	1200000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	4200000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	3800000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	26300000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2023Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1200000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	700000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	7326000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	28735000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	28496000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24542000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	21829000	usd
CY2024Q3	real	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	20200000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	131128000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17367000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	113761000	usd
	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	20690000	usd
	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	27028000	usd
	real	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Including Re Measurement Of Right Of Use Asset And Lease Liabilities RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingReMeasurementOfRightOfUseAssetAndLeaseLiabilities	4074000	usd
	real	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Including Re Measurement Of Right Of Use Asset And Lease Liabilities RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingReMeasurementOfRightOfUseAssetAndLeaseLiabilities	6006000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
	us-gaap	Restructuring Charges RestructuringCharges	37400000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	26300000	usd
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	7500000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	3000000	usd
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1300000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	700000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	292300000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	319400000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3100000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17938000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22949000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65747000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-146779000	usd
CY2024Q3	us-gaap	Dilutive Securities DilutiveSecurities	-744000	usd
CY2023Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18682000	usd
	us-gaap	Restructuring Charges RestructuringCharges	37400000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	26300000	usd
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	7500000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	3000000	usd
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1300000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	700000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	292300000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	319400000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3100000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17938000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22949000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65747000	usd
CY2024Q3	us-gaap	Dilutive Securities DilutiveSecurities	-744000	usd
CY2023Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18682000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22949000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-65747000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109016060	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107043946	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112418751	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102648790	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107043946	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101087793	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22949000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-65747000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-146779000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109016060	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102648790	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107043946	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101087793	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3402691	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112418751	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102648790	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107043946	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101087793	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.45
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.45
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27639102	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34449477	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35533839	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34449477	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.45
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.45
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27639102	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34449477	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35533839	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34449477	shares

Files In Submission

Name	View Source	Status
0001573221-24-000125-index-headers.html	Edgar Link	pending
0001573221-24-000125-index.html	Edgar Link	pending
0001573221-24-000125.txt	Edgar Link	pending
0001573221-24-000125-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
real-20240930.htm	Edgar Link	pending
real-20240930.xsd	Edgar Link	pending
real-20240930xex101.htm	Edgar Link	pending
real-20240930xex102.htm	Edgar Link	pending
real-20240930xex103.htm	Edgar Link	pending
real-20240930xex104.htm	Edgar Link	pending
real-20240930xex311.htm	Edgar Link	pending
real-20240930xex312.htm	Edgar Link	pending
real-20240930xex321.htm	Edgar Link	pending
real-20240930xex322.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
real-20240930_pre.xml	Edgar Link	unprocessable
real-20240930_lab.xml	Edgar Link	unprocessable
real-20240930_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
real-20240930_cal.xml	Edgar Link	unprocessable
real-20240930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REAL
TheRealReal, Inc. Stock $real

2024 Q4 Form 10-Q Financial Statement

#000157322124000125 Filed on November 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL TheRealReal, Inc. Stock $real

2024 Q4 Form 10-Q Financial Statement

#000157322124000125 Filed on November 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL
TheRealReal, Inc. Stock $real